ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)

Japan flag Japan · Delayed Price · Currency is JPY
2,327.00
-29.00 (-1.23%)
At close: Mar 6, 2026
8.43%
Market Cap 66.08B
Revenue (ttm) 68.70B
Net Income (ttm) 4.91B
Shares Out 28.40M
EPS (ttm) 172.94
PE Ratio 13.46
Forward PE 11.99
Dividend 55.00 (2.36%)
Ex-Dividend Date Mar 30, 2026
Volume 58,600
Average Volume 128,590
Open 2,356.00
Previous Close 2,356.00
Day's Range 2,316.00 - 2,356.00
52-Week Range 1,920.00 - 2,942.00
Beta 0.24
RSI 45.93
Earnings Date May 11, 2026

About TYO:4886

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also i... [Read more]

Sector Healthcare
Founded 1920
Employees 1,632
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4886
Full Company Profile

Financial Performance

In fiscal year 2025, TYO:4886's revenue was 64.14 billion, an increase of 2.06% compared to the previous year's 62.84 billion. Earnings were 5.10 billion, a decrease of -32.39%.

Financial Statements

News

There is no news available yet.